Key result
Systemic lupus erythematosus was associated with increased risk of peripartum cardiovascular complications, including preeclampsia (aOR 2.12; 95% CI 2.07-2.17) and heart failure (aOR 4.06).
Why the study?
Individuals with systemic lupus erythematosus have an increased risk of pregnancy-related complications, but data on acute cardiovascular complications during delivery admissions remain limited.
Does systemic lupus erythematosus increase the risk of acute peripartum cardiovascular complications in individuals during delivery hospitalization?
Cross-Sectional (n=63,115,002)
Yes
Does systemic lupus erythematosus increase the risk of acute peripartum cardiovascular complications in individuals during delivery hospitalization?
Pregnant individuals with systemic lupus erythematosus have a significantly higher risk of acute peripartum cardiovascular complications, including peripartum cardiomyopathy, heart failure, and preeclampsia, leading to increased length of stay and hospitalization costs.
May warrant closer peripartum monitoring in SLE; leaves open whether interventions reduce complications.
Importance: Individuals with systemic lupus erythematosus (SLE) have an increased risk of pregnancy-related complications. However, data on acute cardiovascular complications during delivery admissions remain limited. Objective: To investigate whether SLE is associated with an increased risk of acute peripartum cardiovascular complications during delivery hospitalization among individuals giving birth. Design, Setting, and Participants: This population-based cross-sectional study was conducted with data from the National Inpatient Sample (2004-2019) by using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) or International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Clinical Modification (ICD-10-CM) codes to identify delivery hospitalizations among birthing individuals with a diagnosis of SLE. A multivariable logistic regression model was developed to report an adjusted odds ratio (OR) for the association between SLE and acute peripartum cardiovascular complications. Data were analyzed from May 1 through September 1, 2022. Exposure: Diagnosed SLE. Main Outcomes and Measures: Primary study end points were preeclampsia, peripartum cardiomyopathy, and heart failure. Secondary end points included ischemic and hemorrhagic stroke, pulmonary edema, cardiac arrhythmias, acute kidney injury (AKI), venous thromboembolism (VTE), length of stay, and cost of hospitalization. Results: A total of 63 115 002 weighted delivery hospitalizations (median [IQR] age, 28 [24-32] years; all were female patients) were identified, of which 77 560 hospitalizations (0.1%) were among individuals with SLE and 63 037 442 hospitalizations (99.9%) were among those without SLE. After adjustment for age, race and ethnicity, comorbidities, insurance, and income level, SLE remained an independent risk factor associated with peripartum cardiovascular complications, including preeclampsia (adjusted OR [aOR], 2.12; 95% CI, 2.07-2.17), peripartum cardiomyopathy (aOR, 4.42; 95% CI, 3.79-5.13), heart failure (aOR, 4.06; 95% CI, 3.61-4.57), cardiac arrhythmias (aOR, 2.06; 95% CI, 1.94-2.21), AKI (aOR, 7.66; 95% CI, 7.06-8.32), stroke (aOR, 4.83; 95% CI, 4.18-5.57), and VTE (aOR, 6.90; 95% CI, 6.11-7.80). For resource use, median (IQR) length of stay (3 [2-4] days vs 2 [2-3] days; P < .001) and cost of hospitalization ($4953 [$3305-$7517] vs $3722 [$2606-$5400]; P < .001) were higher for deliveries among individuals with SLE. Conclusions and Relevance: This study found that SLE was associated with increased risk of complications, including preeclampsia, peripartum cardiomyopathy, heart failure, arrhythmias, AKI, stroke, and VTE during delivery hospitalization and an increased length and cost of hospitalization.
No takes yet. Share an insight, caveat, or question.
Zahid et al. (2022) conducted a cross-sectional in Systemic lupus erythematosus (n=63,115,002). Diagnosed systemic lupus erythematosus vs. Without systemic lupus erythematosus was evaluated on Preeclampsia, peripartum cardiomyopathy, and heart failure (aOR 2.12 (preeclampsia), aOR 4.42 (cardiomyopathy), aOR 4.06 (heart failure), 95% CI 2.07-2.17 (preeclampsia), 3.79-5.13 (cardiomyopathy), 3.61-4.57 (heart failure)). Systemic lupus erythematosus was associated with increased risk of peripartum cardiovascular complications, including preeclampsia (aOR 2.12; 95% CI 2.07-2.17) and heart failure (aOR 4.06).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: